Nyxoah is trading at $0.90, up 5.28% in pre-market, with no clear company-specific news explaining the rise.

  • Cantor Fitzgerald maintained an Overweight rating while lowering its price target to $3; the action does not clearly account for the upward move.
  • Nyxoah’s October 19 preliminary Q3 report lowered 2026 revenue guidance; it is prior news, not a clear catalyst for this rise.
  • Nyxoah will report Q3 results on November 5.